Literature DB >> 26709761

Nucleotide Excision Repair and head and neck cancers.

Francesco Merolla1, Massimo Mascolo2, Gennaro Ilardi1, Maria Siano1, Daniela Russo1, Vincenzo Graziano1, Angela Celetti3, Stefania Staibano4.   

Abstract

Genome integrity maintenance is crucial for cell survival and for counteracting cancer onset and progression. Mammary cells invest great amount of energy in DNA repair, in order to avoid errors accumulation in DNA sequence. Nucleotide Excision Repair (NER) removes a broad spectrum of DNA damages, mainly bulky DNA lesions. Tissues of Head and Neck region are heavily exposed to bulky lesions inducing carcinogens, this making NER process of great interest in the field. Here we review the recent literature about NER in HNC and we also discuss the role played by NER in HNSCC in the chromatin context; to this aim we particularly focus on the role played by histones chaperon CAF-1, essential in restoring the chromatin structure following DNA replication and DNA damage repair, including NER. A better understanding of basic mechanisms underlying the DNA damage response, particularly involving NER, especially in the chromatin context, will provide us with new promising way to bypass the repair block, possibly becoming an unexpected mode of  "transversal" control also of the proliferative deregulation, classically observed in HNSCC.

Entities:  

Mesh:

Year:  2016        PMID: 26709761     DOI: 10.2741/4376

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  2 in total

1.  In vitro assessment of the role of DpC in the treatment of head and neck squamous cell carcinoma.

Authors:  Ye-Xing Xu; Man-Li Zeng; Di Yu; Jie Ren; Fen Li; Anyuan Zheng; Yong-Ping Wang; Chen Chen; Ze-Zhang Tao
Journal:  Oncol Lett       Date:  2018-03-15       Impact factor: 2.967

2.  CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC.

Authors:  Francesco Morra; Francesco Merolla; Ida Picardi; Daniela Russo; Gennaro Ilardi; Silvia Varricchio; Federica Liotti; Roberto Pacelli; Luca Palazzo; Massimo Mascolo; Angela Celetti; Stefania Staibano
Journal:  Cancers (Basel)       Date:  2019-10-17       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.